- Vicarious Surgical press release (NYSE:RBOT): Q4 Non-GAAP EPS of -$0.07 beats by $0.06.
- Operating expenses were $15.5 million for the fourth quarter of 2023, compared to $20.6 million in the corresponding prior year period, a decrease of 25%.
- Sales and marketing expenses for the fourth quarter of 2023 were $1.2 million, compared to $1.8 million in the fourth quarter of 2022.
Vicarious Surgical Non-GAAP EPS of -$0.07 beats by $0.06
